Prevalence of CYP2C9 and VKORC1 polymorphism carriage in patients of the Chuvash population receiving warfarin
Warfarin is an anticoagulant with proven efficacy in preventing thromboembolic complications in patients with mechanical heart valves. Genetic characteristics of the patient, such as carriage of polymorphisms responsible for its pharmacokinetics (CYP2C9) and pharmacodynamics (VKORC1) are significant when selecting doses of this drug.
Authors
- С. И. Павлова (ORCID: https://orcid.org/0000-0001-9976-7866)
- K Georgieva (ORCID: https://orcid.org/0000-0002-8632-1408)
Publication Details
- Journal
- Glavvrač (Chief Medical Officer)
- Published
- 2025-03-22
- DOI
- https://doi.org/10.33920/med-03-2504-06
- Primary Topic
- Eicosanoids and Hypertension Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00